BAX Baxter International Inc.

Baxter to Present at the UBS Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the UBS Global Healthcare Conference on Tuesday, May 23, 2017 in New York. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 9 a.m. Eastern Time.

The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through July 23, 2017.

Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

EN
19/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Baxter International Inc.

Moody's Ratings affirms Baxter at Baa2; revises outlook to negative fr...

Moody's Ratings (Moody's) affirmed Baxter International Inc.'s (Baxter) ratings, including its Baa2 senior unsecured ratings and Prime-2 commercial paper rating. At the same time, we revised the outlook to negative from stable. The ratings affirmation considers Baxter's good scale and diversity as...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Baxter International Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 17 June 2025 in which we reassessed the appropriateness of the ratings in the con...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch